A detailed history of Congress Asset Management CO transactions in Abb Vie Inc. stock. As of the latest transaction made, Congress Asset Management CO holds 96,739 shares of ABBV stock, worth $16.7 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
96,739
Previous 102,239 5.38%
Holding current value
$16.7 Million
Previous $15.8 Million 11.19%
% of portfolio
0.13%
Previous 0.13%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 11, 2024

SELL
$159.82 - $182.1 $879,010 - $1 Million
-5,500 Reduced 5.38%
96,739 $17.6 Million
Q4 2023

Mar 04, 2024

SELL
$137.6 - $154.97 $685,798 - $772,370
-4,984 Reduced 4.65%
102,239 $15.8 Million
Q3 2023

Nov 01, 2023

BUY
$133.59 - $154.65 $271,722 - $314,558
2,034 Added 1.93%
107,223 $16 Million
Q2 2023

Jul 27, 2023

BUY
$132.51 - $164.9 $43,463 - $54,087
328 Added 0.31%
105,189 $14.2 Million
Q1 2023

Apr 21, 2023

SELL
$144.61 - $166.54 $20,245 - $23,315
-140 Reduced 0.13%
104,861 $16.7 Million
Q4 2022

Jan 18, 2023

SELL
$138.31 - $165.87 $18,948 - $22,724
-137 Reduced 0.13%
105,001 $0
Q3 2022

Nov 08, 2022

BUY
$134.21 - $153.93 $175,949 - $201,802
1,311 Added 1.26%
105,138 $14.1 Million
Q2 2022

Aug 02, 2022

BUY
$137.62 - $174.96 $65,369 - $83,106
475 Added 0.46%
103,827 $15.9 Million
Q1 2022

Apr 20, 2022

BUY
$131.98 - $163.75 $31,411 - $38,972
238 Added 0.23%
103,352 $16.8 Million
Q4 2021

Jan 28, 2022

BUY
$107.43 - $135.93 $212,926 - $269,413
1,982 Added 1.96%
103,114 $14 Million
Q3 2021

Nov 08, 2021

BUY
$106.4 - $120.78 $260,786 - $296,031
2,451 Added 2.48%
101,132 $10.9 Million
Q2 2021

Aug 05, 2021

BUY
$105.21 - $117.21 $258,921 - $288,453
2,461 Added 2.56%
98,681 $11.1 Million
Q1 2021

May 05, 2021

BUY
$102.3 - $112.62 $274,266 - $301,934
2,681 Added 2.87%
96,220 $10.4 Million
Q4 2020

Jan 26, 2021

BUY
$80.49 - $108.67 $403,093 - $544,219
5,008 Added 5.66%
93,539 $10 Million
Q3 2020

Nov 03, 2020

BUY
$85.91 - $100.83 $264,173 - $310,052
3,075 Added 3.6%
88,531 $7.75 Million
Q2 2020

Jul 23, 2020

SELL
$73.37 - $98.18 $73,516 - $98,376
-1,002 Reduced 1.16%
85,456 $8.39 Million
Q1 2020

Apr 21, 2020

BUY
$64.5 - $97.79 $1.13 Million - $1.72 Million
17,586 Added 25.53%
86,458 $6.59 Million
Q4 2019

Feb 10, 2020

SELL
$72.13 - $90.25 $366,059 - $458,018
-5,075 Reduced 6.86%
68,872 $6.1 Million
Q3 2019

Nov 01, 2019

SELL
$62.98 - $75.72 $4.4 Million - $5.3 Million
-69,940 Reduced 48.61%
73,947 $5.6 Million
Q2 2019

Aug 07, 2019

BUY
$65.7 - $83.98 $235,008 - $300,396
3,577 Added 2.55%
143,887 $10.5 Million
Q1 2019

May 08, 2019

BUY
$77.14 - $90.79 $1.16 Million - $1.36 Million
15,027 Added 11.99%
140,310 $11.3 Million
Q4 2018

Jan 25, 2019

SELL
$77.85 - $96.01 $1.06 Million - $1.31 Million
-13,678 Reduced 9.84%
125,283 $11.6 Million
Q3 2018

Oct 26, 2018

SELL
$88.91 - $98.84 $13,425 - $14,924
-151 Reduced 0.11%
138,961 $13.1 Million
Q2 2018

Jul 25, 2018

BUY
$89.78 - $106.23 $4.49 Million - $5.31 Million
49,956 Added 56.03%
139,112 $12.9 Million
Q1 2018

May 11, 2018

SELL
$92.01 - $123.21 $25,302 - $33,882
-275 Reduced 0.31%
89,156 $8.44 Million
Q4 2017

Jan 30, 2018

SELL
$89.56 - $98.21 $2,507 - $2,749
-28 Reduced 0.03%
89,431 $8.65 Million
Q3 2017

Oct 17, 2017

BUY
$69.85 - $89.22 $6.25 Million - $7.98 Million
89,459
89,459 $7.95 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $305B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Congress Asset Management CO Portfolio

Follow Congress Asset Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Congress Asset Management CO , based on Form 13F filings with the SEC.

News

Stay updated on Congress Asset Management CO with notifications on news.